Literature DB >> 43760

Placental and mammary transfer of sulphasalazine.

A K Khan, S C Truelove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 43760      PMCID： PMC1597396          DOI： 10.1136/bmj.2.6204.1553

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Absorption, metabolism, and excretion of salicylazosulfapyridine in man.

Authors:  H Schröder; D E Campbell
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

2.  Distribution studies of salicylazosulfapyridine and its metabolites.

Authors:  M A Peppercorn; P Goldman
Journal:  Gastroenterology       Date:  1973-02       Impact factor: 22.682

3.  Determination of salicylazosulphapyridine in biological materials.

Authors:  M Sandberg; K A Hansson
Journal:  Acta Pharm Suec       Date:  1973-05

4.  Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine.

Authors:  K A Hansson; M Sandberg
Journal:  Acta Pharm Suec       Date:  1973-03

5.  Determination of free and acetylated 5-aminosalicylic acid in serum and urine after administration of salicylazosulphapyridine.

Authors:  K A Hansson
Journal:  Acta Pharm Suec       Date:  1973-05
  5 in total
  18 in total

1.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 3.  Managing IBD Therapies in Pregnancy.

Authors:  Jill K J Gaidos; Sunanda V Kane
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

Review 4.  Inflammatory bowel disease in pregnancy: a review.

Authors:  J P Miller
Journal:  J R Soc Med       Date:  1986-04       Impact factor: 5.344

Review 5.  Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

Review 6.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

7.  Chronic idiopathic ulcerative colitis. Pregnancy and fetal outcome.

Authors:  R R Schade; D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1984-07       Impact factor: 3.199

8.  Effects and treatment of inflammatory bowel disease during pregnancy.

Authors:  Harvinder Brar; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2008-07       Impact factor: 3.275

9.  Maternal drug histories and central nervous system anomalies.

Authors:  K A Winship; D A Cahal; J C Weber; J P Griffin
Journal:  Arch Dis Child       Date:  1984-11       Impact factor: 3.791

Review 10.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.